<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Intravenous tissue plasminogen activator (t-PA) is currently approved by the US Food and Drug Administration (FDA) for the treatment of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> in patients &gt; 18 years of age who present within 3 hours of <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> and meet certain criteria </plain></SENT>
<SENT sid="1" pm="."><plain>We report a case of a 16-year-old, previously healthy female who presented with a basilar <z:mp ids='MP_0006134'>artery occlusion</z:mp> and pontine <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>She was treated with intravenous t-PA approximately 4 hours after the <z:hpo ids='HP_0003674'>onset</z:hpo> of symptoms </plain></SENT>
<SENT sid="3" pm="."><plain>The patient demonstrated a remarkable recovery 6 hours after <z:hpo ids='HP_0003674'>onset</z:hpo> of her symptoms and had minimal deficits on discharge from the hospital 1 week later </plain></SENT>
<SENT sid="4" pm="."><plain>She was found to have a <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and was heterozygous for the prothrombin gene G2010A mutation </plain></SENT>
<SENT sid="5" pm="."><plain>These were likely contributing causes for her <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>She was also homozygous for plasminogen activator inhibitor 1 (PAI-1) 4G/4G, which at present is a controversial <z:hpo ids='HP_0001297'>stroke</z:hpo> risk factor </plain></SENT>
</text></document>